5-azacitidine in combination with donor lymphocyte infusions for the treatment of patients with MDS or AML relapsing after allogeneic stem cell transplantation.

被引：2
|
作者：
Czibere, Akos
Graef, Thorsten
Lind, Jens
Gattermann, Norbert
Zohren, Fabian
Fenk, Roland
Haas, Rainer
Kobbe, Guido
机构：
[1] Univ Dusseldorf, Dept Haematol & Oncol, Clin Immunol, D-4000 Dusseldorf, Germany
[2] Harvard Univ, Harvard Inst Med & Stem Cell, Boston, MA 02115 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.5341.5341
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5341
引用
收藏
页码：428B / 428B
页数：1
相关论文
共 50 条
  • [31] In vivo effect of 5-azacitidine treatment in regulatory T cells in patients with AML/MDS
    Buenasmananas, D.
    Serrano-Lopez, J.
    Serrano, J.
    Casano, J.
    Garcia-Torres, E.
    Martinez-Losada, C.
    Chic, C.
    Llamas, M. J.
    Figueroa, V.
    Sanchez-Garia, J.
    LEUKEMIA RESEARCH, 2013, 37 : S131 - S132
  • [32] Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation
    B N Savani
    A Montero
    R Kurlander
    R Childs
    N Hensel
    A J Barrett
    Bone Marrow Transplantation, 2005, 36 : 1009 - 1015
  • [33] Donor lymphocyte infusions in patients with haematological malignancies being treated with an allogeneic stem cell transplantation. A single centre experience
    Jansen, A.
    Hall, J.
    Craig, J.
    Crawley, C.
    Sureda, A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S501 - S501
  • [34] Bortezomib Plus Dexamethasone Followed by Escalating Donor Lymphocyte Infusions for Patients with Multiple Myeloma Relapsing or Progressing after Allogeneic Stem Cell Transplantation
    Montefusco, Vittorio
    Spina, Francesco
    Patriarca, Francesca
    Offidani, Massimo
    Bruno, Benedetto
    Montanari, Mauro
    Mussetti, Alberto
    Sperotto, Alessandra
    Scortechini, Ilaria
    Dodero, Anna
    Fanin, Renato
    Valagussa, Pinuccia
    Corradini, Paolo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (03) : 424 - 428
  • [35] Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation
    Savani, BN
    Montero, A
    Kurlander, R
    Childs, R
    Hensel, N
    Barrett, AJ
    BONE MARROW TRANSPLANTATION, 2005, 36 (11) : 1009 - 1015
  • [36] Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) In Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Interim-Analysis From the AZARELA-Trial (NCT-00795548).
    Schroeder, Thomas
    Czibere, Akos Gabor
    Kroeger, Nicolaus
    Platzbecker, Uwe
    Bug, Gesine
    Rieger, Kathrin
    Luft, Thomas
    Bruns, Ingmar
    Zohren, Fabian
    Wolschke, Christine
    Fenk, Roland
    Haas, Rainer
    Kobbe, Guido
    BLOOD, 2010, 116 (21) : 554 - 554
  • [37] Effectiveness of 5-azacitidine (5-aza) for the treatment of patients with acute myeloidleukaemia (AML) who relapsed after haematopoietic stem cell transplantation (HSCT)
    Garcia-Torres, E.
    Serrano, J.
    Casano, J.
    De la Fuente, A.
    Bergua, J.
    Falantes, J.
    Lopez, J.
    Buenasmananas, D.
    Martinez-Losada, C.
    Romero, A.
    Vera, J.
    Martin-Reina, M.
    Martin-Chacon, E.
    Sanchez, J.
    Martin, C.
    Torres, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S259 - S259
  • [38] REVISITING GVL EFFECT OF AZACITIDINE TREATMENT IN RELAPSED MDS PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Cho, S. G.
    Kim, S. Y.
    Cho, B. S.
    Kim, M.
    Eom, K. S.
    Kim, Y. J.
    Kim, H. J.
    Lee, S.
    Min, C. K.
    Kim, D. W.
    Lee, J. W.
    Min, W. S.
    Park, J. W.
    Kim, C. C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 281 - 281
  • [39] Donor lymphocyte infusions in paediatric patients with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
    Kramm, C
    Kameda, G
    Laws, HJ
    Göbel, U
    BONE MARROW TRANSPLANTATION, 2002, 30 : S62 - S62
  • [40] Hodgkin Lymphoma relapsing after Allogeneic Stem Cell Transplantation: The efficacy of Brentuximab Vedotin in combination with Donor Lymphocyte Infusion
    Tsirigotis, P.
    Yerushalmi, R.
    Gkirkas, K.
    Shemtov, N.
    Danylesko, I.
    Stamouli, M.
    Avigdor, A.
    Spyridonidis, A.
    Goldstein, G.
    Mohty, M.
    Shimoni, A.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S501 - S501
12345